Impact of Consensus Molecular Subtyping (CMS) on overall survival (OS) and Progression Free Survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance).
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 3511
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3029
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GI
- Pharmas:
- Genentech, Eli Lilly, Pfizer
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Heinz-Josef Lenz Fang-Shu Ou Alan P. Venook Howard S. Hochster Donna Niedzwiecki Richard Goldberg Robert Mayer Monica Bertagnolli Charles David Blanke Tyler Zemla Xueping Qu Omar Kabbarah Federico Innocenti
- Networks:
- CA011, CA824, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: